Can Psychopathy be Prevented? Clinical, Neuroimaging and Genetic Data

Sponsor
Universidad Nacional Autonoma de Mexico (Other)
Overall Status
Completed
CT.gov ID
NCT06028620
Collaborator
(none)
25
1
2
28
0.9

Study Details

Study Description

Brief Summary

The goal of this clinical trial was to learn about the effect of maltreatment on psychological and brain characteristics in a group of children. The main question it aims to answer are: which are the clinical characteristics of maltreated children before and after a psychological intervention? what changes in brain emotional processing after a psychological intervention? and what is the effect of serotonin transporter variants after a psychological therapy? Participants were assessed before and after intervention with:

  • clinical measures of anxiety, depression post-traumatic stress and callous-unemotional traits

  • functional neuroimaging techniques to measure brain activity.

  • A sample of buccal epithelial cells to obtain information on serotonin transporter.

Researchers will compare maltreated children with a group on non-maltreated children to see if there are differences on psychological characteristics and on brain activity before treatment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Trauma Focused-Cognitive Behavior Therapy
N/A

Detailed Description

Participants Twenty-five children who suffered child abuse were initially referred by a non-governmental shelter in Mexico City. Children were removed from their homes and placed at the shelter because one or both parents were undergoing judicial processes for various crimes, including child abuse. None of the children had ever received psychological therapy because the shelter did not have a protocol for psychological intervention. After a thorough search for the most appropriate therapy, the TF-CBT was chosen. The information was shared with the shelter administrative board. Once authorities and health professionals at the shelter were informed about the aim of the study, they agreed about the appropriateness of the intervention. A group of trained psychologists would apply the TF-CBT as part of the research protocol. Only children who met the inclusion criteria would participate. Parents or primary caregivers gave their informed written consent for their children to participate in the study. Ethical approval of the study was granted, and the research was performed in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki).

The final sample consisted of an experimental group of 14 MC which included 4 boys and 10 girls (mean age = 8.77 years old, S.D.=1.83), who had experienced a positive history of different types of trauma, and a control group of 10 HC from the general population who were developing normally and were age-matched to the MC (4 boys and 6 girls) (mean age = 9.57 years old, S.D. = 1.91). They were recruited through an advertisement placed at the Faculty of Psychology, National Autonomous University of Mexico (UNAM) or by direct referral from parents of previous participants in other studies. All were residents of Mexico City. The study protocol was conducted with the approval of the UNAM Institutional Review Board.

Clinical scales A comprehensive clinical battery was used to assess all participants through the administration of the following assessment tools: The Child Depression Inventory (CDI) Spanish version (Del Barrio & Carrasco, 2004). The Spence Children's Anxiety Scale (SCAS) standardized on a sample of Mexican children by Hernández et al (Hernández-Guzmán et al., 2010), the Child PTSD Symptom Scale (CPSS) Spanish version (Bustos et al., 2009), and the Inventory of Callous Unemotional Traits (ICU) Spanish version (López-Romero et al., 2015) including three subscales for callousness, uncaring, and unemotional (Frick, 2004).

Procedure The MC group was assessed before and after the implementation of Trauma Focused-Cognitive Behavior Therapy (TF-CBT) using clinical scales and an emotion paradigm through functional magnetic resonance imaging (fMRI). The HC group was also assessed and scanned twice.

Of the total sample, 14 MC completed the TF-CBT modules and came in for their post-treatment assessment session. In addition, the 10 HC who, according to their parents, had not completed any type of psychological intervention during those 4 months, and still met the inclusion criteria for the initial control group were selected and returned for their post-evaluation session.

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Can Psychopathy be Prevented? Clinical, Neuroimaging and Genetic Data
Actual Study Start Date :
Feb 1, 2020
Actual Primary Completion Date :
Nov 1, 2021
Actual Study Completion Date :
Jun 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Maltreated children

The Maltreated Children group was assessed before and after a psychological intervention using clinical scales (anxiety, depression, post-traumatic stress disorder and Callous unemotional traits) and an emotion paradigm through functional magnetic resonance imaging (fMRI). The psychological intervention implemented with the maltreated group was the Trauma Focused-Cognitive Behavior Therapy. For this study, 12 to 16 sessions of 60-90 min each, were implemented once a week for 4 months. 14 out of 15 maltreated children completed the TF-CBT units and one week after that, they underwent the post-treatment assessment.

Behavioral: Trauma Focused-Cognitive Behavior Therapy
TF-CBT consisted of 8 units in which different issues realted to trauma are reviewed. Units are: psychoeducation and parenting skills, relaxation techniques, affective expression and regulation, cognitive coping and processing, trauma narrative and processing, in vivo exposure, co-joint sessions and enhancing safety and future growth.

No Intervention: Healthy Control group

This group did not have any records of maltreatment. They were assessed using clinical scales (anxiety, depression, post-traumatic stress disorder and Callous unemotional traits) and an emotion paradigm through functional magnetic resonance imaging (fMRI). Their scores and brain images were compared with the maltreatment group before this group underwent psychological treatment.

Outcome Measures

Primary Outcome Measures

  1. Correlations between brain regions and clinical traits after psychological treatment [6 months]

    Post treatment scores on callous-unemotional traits (possible scores from 0 - to 43), depression (possible scores from 0 to 274, and PTSD (possible scores from 0 - 17) will be correlated with brain activation changes post treatment in regions of interest. Lower scores in clinical scales after treatment means a lower clinical symptom. Brain regios activations will be obtained with a fmri scan. BOLD response will be measured in each brain region.

Secondary Outcome Measures

  1. Clinical differences at pre treatment between maltreatment group and healthy control [1 month]

    Characteristics of clinical traits before treatment in maltreatment and healthy control group.

  2. Clinical improvement after treatment [6 months]

    A Reliable Change Index >1.96 will be obtained fron callous-unemotional, depression and PTSD scales of each participant. This index indicates a significant clinical improvement.

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

For maltreated children group (MC)

  • Ages between 7 to 12 years old

  • History of trauma or abuse

  • Symptoms of Post traumatic stress disorder

  • Symptoms of anxiety

For healthy control (HC)

  • Ages between 7 to 12 years old

  • No history of trauma or abuse

  • Absence or low symptoms of Post Traumatic Stress Disorder

  • Absence or low symptoms of anxiety

Exclusion Criteria:

• Any neurodevelopmental, medical condition or risk factor other than maltreatment.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Facultad de Psicología UNAM Mexico City Mexico

Sponsors and Collaborators

  • Universidad Nacional Autonoma de Mexico

Investigators

  • Principal Investigator: Feggy Ostrosky, Ph.D., Facultad de Psicología UNAM

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Feggy Ostrosky Shejet, Head of Neuropsychology and Psychophisiology Laboratory, Universidad Nacional Autonoma de Mexico
ClinicalTrials.gov Identifier:
NCT06028620
Other Study ID Numbers:
  • A1-S-13501
First Posted:
Sep 8, 2023
Last Update Posted:
Sep 8, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Feggy Ostrosky Shejet, Head of Neuropsychology and Psychophisiology Laboratory, Universidad Nacional Autonoma de Mexico
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 8, 2023